news

Cramer's Lightning Round: BioXcel Therapeutics May Be Home Run Or Nothing

Cramer’s Lightning Round: BioXcel Therapeutics May Be Home Run Or Nothing
CNBC
  • It's that time again! "Mad Money" host Jim Cramer rings the lightning round bell, which means he's giving his answers to callers' stock questions at rapid speed.

4D Molecular Therapeutics Inc: "Regeneron is the horse to bet on, because it's been a great investment."

WATCH ANYTIME FOR FREE

icon

Stream NBC10 Boston news for free, 24/7, wherever you are.

SoFi Technologies Inc: "I do believe it's bottoming, but I don't know what gets it higher."

BioXcel Therapeutics Inc: "It may be home run or nothing, and that's always tough."

Veru Inc: "The test for [the company's Covid treatment pill] ... The FDA staff didn't seem to like it."

Sign up now for the CNBC Investing Club to follow Jim Cramer's every move in the market.

Disclaimer

Questions for Cramer?
Call Cramer: 1-800-743-CNBC

Want to take a deep dive into Cramer's world? Hit him up!
Mad Money Twitter - Jim Cramer Twitter - Facebook - Instagram

Questions, comments, suggestions for the "Mad Money" website? madcap@cnbc.com

Copyright CNBC
Contact Us